Published in Vaccine Weekly, July 9th, 2003
According to a study from Spain and Switzerland, "MVA is a candidate vector for vaccination against pathogens and tumors. Little is known about its behavior in mucosal tissues. We have investigated the fate and biosafety of MVA, when inoculated by different routes in C57BL/6 mice."
"Intranasal inoculation targeted the virus to the nasal associated lymphoid tissue and the lungs, whereas systemic inoculation led to distribution of MVA in almost all lymphoid organs, lungs, and ovaries," reported J. C. Ramirez and collaborators...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly